WEED, Inc. Expands WEED(R) Brand and Adds PANAMA RED(TM) and ACAPULCO GOLD(TM) to its Growing Brand Portfolio


Brand expansion is a key part of the company’s growth plan to secure intellectual property rights in the cannabis industry globally

TUCSON, AZ /ACCESSWIRE/April 7, 2022/ WEED, Inc. (OTCQB: BUDZ) (“WEED” or the “Company”) a U.S.-based global cannabis and hemp bioresearch company focused on the development and application of cannabis-derived compounds for the Treatment of Human and Animal Diseases, today announced that it is focused on growing its brand portfolio with industry-registered brands. WEED, Inc. already has federal registration for its WEED® brand with the United States Patent and Trademark Office (USPTO) and the European Community Trademark Office for a variety of smoking accessories (vape cartridges and packaging). WEED, Inc. is currently pursuing a number of federal applications for its WEED®, PANAMA RED™, and ACAPULCO GOLD™ trademarks to cover a broad range of products (rolling papers, grinders, tobacco pipes) and services, including nutritional supplements for medicated preparations for cats, dogs and pets, namely for joint mobility management; also providing education, information and news on cannabis health and medical research, social networking software and organizing concerts and festivals.

“WEED festivals in the scope and range of Woodstock and American festivals from the earliest days have always been on my mind and goals as I was a national concert promoter and producer throughout the 1970s and 80s”, commented our CEO, Glenn E. Martin.

The expanded federal registration of its marks is part of WEED’s broader effort. to expand its intellectual property (IP) trademarks division into a variety of goods and services beyond those offered as part of its core goods and services, namely the development of cannabis-derived healthcare products and cannabis products for adult use. Among other measures, WEED, Inc. has sought to expand its WEED® brand and other related brands, including PANAMA RED™, ACAPULCO GOLD™ and WEED RULES! ™ for goods and services which include cosmetics and cleaning products, paper goods and printed matter, and natural agricultural products in addition to others by filing multiple trademark applications with the USPTO. “By protecting and expanding existing trademark rights and acquiring additional intellectual property rights, we will strengthen WEED, Inc.’s brand recognition and leadership position in the cannabis industry and create value for consumers. shareholders beyond that created by the company’s core business.” comments Glenn E. Martin, President and CEO of WEED, Inc. “We believe that the majority of discoveries in cannabis and hemp are still to find. We believe these exciting times will change global health around the world! WEED’s leading scientists are already working on new breeding programs, genetic modifications, formulations and drug delivery systems for humans and companion animals.

Past reviews of WEED, Inc. affiliates from 2021/2022

WEED Israel (Cannabis) Ltd. “After more than 2 years of suspending human clinical trials and product development due to COVID, WEED Israel is poised and eager to grow our global brands across pharmaceutical and non-pharmaceutical categories, starting with women’s health. and veteran ailments (PTSD) to green and healthy alternative medicines,” said Elliot Kwestel, Managing Director of WEED Israel (Cannabis) Ltd. based outside of Jerusalem. Kwestel further commented, “WEED Israel seeks to enrich and expand our clinical trials with studies of THC and cannabinoids to promote healthy living for generations to come.

WEED Australia Ltd. and The Australian Cannabis Institute (CIA), our not-for-profit Australian branch, based in Queensland on the Gold Coast. Chief Executive Patrick Brodnik said: “With the new rules governing cannabis and hemp in Australia and the announcement of the 1st February 2021 to allow over-the-counter CBD drugs in pharmacies, now is the perfect time to begin our clinical trials in Israel and Australia to bring new curative products to market as we close out COVID mandates this year. Managing Director Brodnik continues, “This year 2022, the future of cannabis and hemp decriminalization around the world will prove to be a giant leap forward for the global legalization of cannabis.”

WEED HongKong Ltd. Director Nicole Breen agrees: “The pandemic has affected us all around the world. Healing our planet with natural therapies, treatments and possible “cures” using nature’s own Cannabaceae plant with its many properties, both with compounds high in tetrahydrocannabinol (THC) and cannabidiol (CBD) , I think this will change the force of medicine forever in the years to come. We look forward to an exciting end to the year and a prosperous 2022. »

Caution regarding cannabis operations in the United States

Investors should note that there are significant legal restrictions and regulations governing the cannabis industry in the United States. Although legal in some states, cannabis remains a Schedule I drug under the United States Controlled Substances Act, making it illegal under federal law in the United States, among other things, cultivation, distribution or possession of cannabis. Financial transactions involving proceeds generated by, or intended to promote, commercial cannabis-related activities in the United States may form the basis of prosecution under applicable United States federal money laundering laws. Investors should carefully read the risk factors and information contained in our offering circular before making a decision to invest in our company.

Forward-looking information

This press release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information in this press release can be identified by the use of words such as “may”, “could”, “might”, “will”, “likely”, “expect”, “anticipate”. , “believes”, “intends”, “plans”, “expects”, “projects”, “estimates”, “prospects” and other similar expressions, and include statements regarding future revenues and profits. Forward-looking information is not a guarantee of future performance and is based on a number of management estimates and assumptions in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions regarding current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits.

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on forward-looking information as the Company cannot guarantee that it will prove to be accurate. Actual results and developments may differ materially from those contemplated by such statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. The statements contained in this press release are made as of the date of this press release. The Company disclaims any intention or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

Legal notice

The information is provided for convenience only, does not constitute investment advice, and should not be relied upon in considering an investment in WEED, Inc. No representations or warranties, express or implied, are made as to the accuracy or completeness of the information contained herein, and any investment decision should be based solely on the information contained in the offering circular and related documents, as well as independent investor research. No representation or warranty, express or implied, is made as to the future performance of any investment in WEED, Inc. or that investors will obtain or are likely to obtain favorable results, make any profit or be able to avoid incurring a loss on their investment. In addition, prospective investors are encouraged to consult their financial, tax, accounting or other advisors to determine whether an investment in WEED, Inc. is suitable for them.

Media Contact:
Glenn E. Martin, CEO
[email protected]


See the source version on accesswire.com:

Source link


Comments are closed.